The purpose of this paper is to examine the extent to which corporate governance have impact on financial performance of selected companies in pharma sector . The study analyses whether there is any significant relationship between the board meeting, board size, board committee and composition of board with ROCE & EPS of the selected pharma companies. The paper studies the annual reports of top 5 large cap companies, mid cap companies, small cap companies. The study period considered for one year i.e., 2020 to 2021.The score is given on a three-point scale from 0 to 2 . The study shows there is no significant impact of corporate governance on financial performance of selected companies in pharma companies irrespective of their market capitalisation . The selected companies have impressive level of corporate governance practices and all companies follows SEBI LODR regulations 2015 which is mandatory to be followed by all listed companies.